Processing 00000000.tx.1: Rockefeller University Press, 0022-1007/2002/7/269/ $5.00 The Journal of Experimental Medicine, Volume 196, Number 2, July 15, 2002 269-274 Brief Definitive Report Potential Role of Phosphatidylinositol 3 Kinase, rather than DNA-dependent Protein Kinase, in CpG DNAinduced Immune Activation Ken J. 

Phrase: "Rockefeller University Press,"

Phrase: "0022-1007/2002/7/269/ $5.00"

Phrase: "The Journal of Experimental Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Volume 196,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "July 15,"

Phrase: "2002 269-274 Brief Definitive Report Potential Role of Phosphatidylinositol 3 Kinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "rather than"

Phrase: "DNA-dependent Protein Kinase,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0212694:DNA-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335262:DNA-DEPENDENT PROTEIN KINASE [Gene or Genome]
   902   C0032545:DNA Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1418707:DNA KINASE [Gene or Genome]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in CpG DNAinduced Immune Activation Ken J."
Processing 00000000.tx.2: Ishii1, Fumihiko Takeshita1, Ihsan Gursel1, Mayda Gursel1, Jacqueline Conover1, Andre Nussenzweig2 and Dennis M. 

Phrase: "Ishii1,"

Phrase: "Fumihiko Takeshita1,"

Phrase: "Ihsan Gursel1,"

Phrase: "Mayda Gursel1,"

Phrase: "Jacqueline Conover1,"

Phrase: "Andre Nussenzweig2"

Phrase: "and"

Phrase: "Dennis M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Klinman1 1 Section of Retroviral Immunology, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration 2 Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Address correspondence to Dennis M. 

Phrase: "Klinman1 1 Section of Retroviral Immunology,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205155:Section [Spatial Concept]
   753   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   753   C1522472:Section [Substance]
   753   C1552923:Section [Quantitative Concept]
   753   C1705191:Section [Physical Object]

Phrase: "Division of Viral Products,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "Center for Biologics Evaluation and Research,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C2826367:Center for Biologics Evaluation and Research [Professional or Occupational Group]
   895   C0683939:center research [Manufactured Object,Organization]
   839   C0015195:Evaluation Research [Research Activity]
   810   C2984638:BIOLOGIC EVALUATION [Functional Concept]
   799   C0005522:Biologics [Biologically Active Substance,Pharmacologic Substance]
   799   C0035168:research [Research Activity]
   799   C0205099:Center [Spatial Concept]
   799   C0220825:Evaluation [Functional Concept]
   799   C0242481:Research [Research Activity]
   799   C1261322:Evaluation [Health Care Activity]
   799   C2979985:Biologics [Biologically Active Substance,Pharmacologic Substance]
   766 E C0205460:Biologic [Qualitative Concept]

Phrase: "Food and Drug Administration 2 Experimental Immunology Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1253959:Branch [Body Part, Organ, or Organ Component]
   793   C1881507:Branch [Chemical Viewed Structurally]
   793   C2700383:Branch [Plant]
   793   C2826234:BRANCH [Intellectual Product]

Phrase: "National Cancer Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1513882:National Cancer Institute [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0021622:institute [Organization]
   827   C0998265:Cancer [Eukaryote]
   827   C1272753:Institute [Idea or Concept]
   827   C1306459:Cancer [Finding]
   827   C3245503:national [Intellectual Product]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "MD 20892 Address correspondence to Dennis M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.4: Klinman, Bldg. 

Phrase: "Klinman,"

Phrase: "Bldg."
Processing 00000000.tx.5: 29A, Rm. 

Phrase: "29A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553667:29a [Medical Device]

Phrase: "Rm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2951520:RM [Body Location or Region]
Processing 00000000.tx.6: 3D10, CBER/FDA, Bethesda, MD 20892. 

Phrase: "3D10,"

Phrase: "CBER/FDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041714:FDA [Health Care Related Organization]

Phrase: "Bethesda,"

Phrase: "MD 20892."
Processing 00000000.tx.7: Phone: 301-827-1707; 

Phrase: "Phone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1515258:Phone [Conceptual Entity]
  1000   C1705541:Phone [Manufactured Object]
   907 E C0042939:Voice [Organism Function]
   907 E C3244282:voice [Qualitative Concept]
   893 E C0205382:Vocal [Functional Concept]
   893 E C0871074:phonic [Intellectual Product]

Phrase: ":"

Phrase: "301-827-1707"

Phrase: ";"
Processing 00000000.tx.8: Fax: 301-496-1810; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "301-496-1810"

Phrase: ";"
Processing 00000000.tx.9: E-mail: klinman{at}cber.fda.gov  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Unmethylated CpG motifs present in bacterial DNA stimulate a strong innate immune response. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "klinman{at}cber.fda.gov  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Unmethylated CpG motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1514562:Motif [Amino Acid Sequence]

Phrase: "present in bacterial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C0521009:Bacterial [Qualitative Concept]

Phrase: "stimulate"

Phrase: "a strong innate immune response."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0020969:Innate Immune Response [Organism Attribute,Pathologic Function]
   861   C0301872:Immune response [Organ or Tissue Function]
   812   C0439662:Immune [Functional Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
Processing 00000000.tx.10: There is evidence that DNA-dependent protein kinase (DNA-PK) mediates CpG signaling. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that DNA-dependent protein kinase (DNA-PK)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0212694:DNA-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335262:DNA-DEPENDENT PROTEIN KINASE [Gene or Genome]
   902   C0032545:DNA Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1418707:DNA KINASE [Gene or Genome]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "CpG signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.11: Specifically, wortmannin (an inhibitor of phosphatidylinositol 3 kinase [PI3]-kinases including DNA-PK) interferes with CpG-dependent cell activation, and DNA-PK knockout (KO) mice fail to respond to CpG stimulation. 

Phrase: "Specifically,"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "("

Phrase: "an inhibitor of phosphatidylinositol 3 kinase [PI3]-kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1519050:Phosphatidylinositol 3-kinase Inhibitor [Pharmacologic Substance]
   774   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   774   C3537023:kinase inhibitor [Molecular Function]
   774   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "interferes with CpG-dependent cell activation,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0521102:Interferes with [Qualitative Concept]
           Interfere
   790   C1326120:cell activation [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1879547:Activation [Activity]
   753   C1948049:Cell [Spatial Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "DNA-PK knockout (KO) mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "respond to CpG stimulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.12: Current studies establish that wortmannin actually inhibits the uptake and colocalization of CpG DNA with toll-like receptor (TLR)-9 in endocytic vesicles, thereby preventing CpG-induced activation of the NF-B signaling cascade. 

Phrase: "Current studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that wortmannin actually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "colocalization of CpG DNA"

Phrase: "with toll-like receptor (TLR)-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "in endocytic vesicles,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887883:Endocytic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "thereby"

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "CpG-induced activation of the NF-B signaling cascade."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]
Processing 00000000.tx.13: We find that DNA-PK is not involved in this process, since three strains of DNA-PK KO mice responded normally to CpG DNA. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in this process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "since"

Phrase: "three strains of DNA-PK KO mice"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C1513684:Mouse Strains [Mammal]
   744   C0080194:Strains [Injury or Poisoning]
   744   C0456178:strains [Intellectual Product]
   711 E C1518614:Strain [Organism]
   711 E C2987481:Strain [Mental Process]

Phrase: "responded"

Phrase: "normally to CpG DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.14: These results support a model in which CpG signaling is mediated through TLR-9 but not DNA-PK, and suggest that wortmannin-sensitive member(s) of the PI3-kinase family play a critical role in shuttling CpG DNA to TLR-9. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a model in which CpG signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "mediated through TLR-9"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   833   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   753   C1336636:TOLL [Gene or Genome]
   753   C1705581:TOLL [Gene or Genome]

Phrase: "but"

Phrase: "not DNA-PK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that wortmannin-sensitive member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0680022:member [Population Group]
   827   C2698041:Member [Professional or Occupational Group]

Phrase: "("

Phrase: "s) of the PI3-kinase family"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinase
   744   C0015576:Family [Family Group]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C1704727:Family [Conceptual Entity]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C2603362:S' [Clinical Attribute]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in shuttling CpG DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "to TLR-9."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]
Processing 00000000.tx.15: Key Words: toll-like receptors  wortmannin  dendritic cells  innate immunity  cytokines  Introduction Top Abstract Introduction Materials and Methods Results Discussion References  Toll-like receptors (TLRs) mediate host recognition of "pathogen-associated molecular patterns" expressed by infectious microorganisms (1). 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "toll-like receptors  wortmannin  dendritic cells  innate immunity  cytokines  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Toll-like receptors (TLRs)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0670896:Toll-like receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   827   C1336636:TOLL [Gene or Genome]
   827   C1705581:TOLL [Gene or Genome]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "host recognition of ""pathogen-associated molecular patterns"""
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   795   C0332281:Associated [Qualitative Concept]
   795   C0449774:Patterns [Spatial Concept]
   795   C0450254:Pathogen [Organism]
   795   C1521991:Molecular [Qualitative Concept]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]
   724 E C0567416:Molecule [Substance]

Phrase: "expressed by infectious microorganisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0445623:Microorganisms [Organism]
   737 E C2827713:Microorganism [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Engagement of TLR triggers an innate immune response that promotes the elimination of foreign pathogens and supports the development of adaptive immunity (2). 

Phrase: "Engagement of TLR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425152:engagement [Finding]
   760   C2937292:engagement [Finding]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "an innate immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0020969:Innate Immune Response [Organism Attribute,Pathologic Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the elimination of foreign pathogens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0221102:Elimination [Physiologic Function]

Phrase: "and"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the development of adaptive immunity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: For example, "CpG motifs" present at high frequency in bacterial, but not mammalian DNA, interact with TLR-9, stimulating an immune response characterized by the production of cytokines, chemokines, and Ig by B lymphocytes, NK cells, macrophages, and dendritic cells (DCs; references 36). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: """CpG motifs"" present at high frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "in bacterial,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0521009:Bacterial [Qualitative Concept]
   928 E C0004611:Bacteria [Bacterium]
   928 E C1510439:bacteria [Functional Concept]
   928 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "but"

Phrase: "not mammalian DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "interact with TLR-9,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   833   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   753   C1336636:TOLL [Gene or Genome]
   753   C1705581:TOLL [Gene or Genome]

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "an immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "characterized by the production of cytokines,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1327413:cytokine production [Organism Function]
   753   C0033268:production [Occupational Activity]
   753   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1880022:Characterized [Activity]

Phrase: "chemokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Ig by B lymphocytes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C3541296:IG [Idea or Concept]

Phrase: "NK cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0022688:NK Cells [Cell]
           NK
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "macrophages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "and"

Phrase: "dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(DCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268238:DCS [Disease or Syndrome]

Phrase: ";"

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.18: Previous studies established that CpG DNA interacts with TLR-9 in endosomal vesicles, triggering a signaling cascade involving NF-Bdependent pathways (79). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "interacts with TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   833   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   753   C1336636:TOLL [Gene or Genome]
   753   C1705581:TOLL [Gene or Genome]

Phrase: "in endosomal vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "a signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2611812:signaling cascade [Cell Function]
   861   C1707310:Cascade [Manufactured Object]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "NF-Bdependent pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.19: Independently, Chu et al. recently reported that the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) has a central role in CpG-mediated immune activation (10). 

Phrase: "Independently,"

Phrase: "Chu et al. recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1335262:DNA-DEPENDENT PROTEIN KINASE, CATALYTIC SUBUNIT [Gene or Genome]
   881   C3536788:DNA-Dependent Protein Kinase Catalytic Subunit [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0600499:Catalytic Subunit [Amino Acid Sequence]
   767   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "has"

Phrase: "a central role in CpG-mediated immune activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.20: Their findings imply that CpG motifs must interact with two independent receptor molecules (TLR-9 and DNA-PKcs) before eliciting an innate immune response (11). 

Phrase: "Their findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "imply"

Phrase: "that CpG motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "must"

Phrase: "interact with two independent receptor molecules"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0085862:Independent [Idea or Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0567416:molecules [Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1299583:Independent [Finding]

Phrase: "(TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "and"

Phrase: "DNA-PKcs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "before"

Phrase: "eliciting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449265:elicit [Qualitative Concept]

Phrase: "an innate immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0020969:Innate Immune Response [Organism Attribute,Pathologic Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.21: DNA-PK consists of three subunits (DNA-PKcs, Ku70, and Ku80) that play a critical role in DNA repair and V(D)J recombination (1921). 

Phrase: "DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "consists of three subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205449:Three [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   737   C1711351:Subunit [Quantitative Concept]

Phrase: "(DNA-PKcs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Ku70,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705873:Ku70 [Gene or Genome]
  1000   C1823878:Ku70 [Gene or Genome]

Phrase: "and"

Phrase: "Ku80"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337034:Ku80 [Gene or Genome]
  1000   C1710692:Ku80 [Gene or Genome]

Phrase: ")"

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in DNA repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "V(D)J recombination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519877:V(D)J Recombination [Genetic Function]
           V-J recombination
   812   C0034865:Recombination [Genetic Function]

Phrase: "(1921"

Phrase: ")."
Processing 00000000.tx.22: Other members of the phosphatidylinositol 3-kinase (PI3)-kinase family contribute to the phosphorylation of membrane inositol lipids involved in signal transduction and membrane transport (12, 13), facilitate the uptake and processing of foreign molecules, and contribute to phagosome formation and maturation (1417). 

Phrase: "Other members of the phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0812311:MEMBER 3 [Gene or Genome]
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "(PI3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")-"

Phrase: "kinase family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "contribute to the phosphorylation of membrane inositol lipids"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0025249:Membrane Lipids [Cell Component,Lipid]
   767   C3268441:inositol phosphorylation [Molecular Function]
   750   C1327207:lipid phosphorylation [Molecular Function]
   744   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   744   C0023779:Lipids [Lipid]
   744   C0025255:Membrane [Tissue]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0596901:Membrane [Cell Component]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1706182:Membrane [Manufactured Object]
   744   C1880177:Contribute [Activity]

Phrase: "involved in signal transduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0037083:Signal Transduction [Cell Function]
   770   C1160185:transduction [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "membrane transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519624:Membrane Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "(12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "facilitate"

Phrase: "the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "processing of foreign molecules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "contribute to phagosome formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1159765:phagosome formation [Cell Function]
   770   C0031310:Phagosome [Cell Component]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1880177:Contribute [Activity]
   770   C2984574:Phagosome [Functional Concept]

Phrase: "and"

Phrase: "maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]

Phrase: "(1417"

Phrase: ")."
Processing 00000000.tx.23: Wortmannin inhibits these events by blocking the conserved ATP-binding site present in the catalytic domain of the PI3-kinase family (18). 

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "these events by blocking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]

Phrase: "the conserved ATP-binding site present in the catalytic domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0150312:Present [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]

Phrase: "of the PI3-kinase family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   853   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.24: This work examines the mechanism by which wortmannin inhibits CpG-induced cellular activation and reexamines the involvement of DNA-PK in this process. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "examines"

Phrase: "the mechanism by which wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "CpG-induced cellular activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "reexamines"

Phrase: "the involvement of DNA-PK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.25: Results indicate that wortmannin inhibits the uptake and/or entry of CpG DNA into TLR-9-containing endocytic vesicles. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and/or"

Phrase: "entry of CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705654:Entry [Intellectual Product]

Phrase: "into TLR-9-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "endocytic vesicles."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887883:Endocytic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.26: In contrast to the report by Chu et al. 

Phrase: "In contrast to the report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "by Chu et al."
Processing 00000000.tx.27: (10), DNA-PK was not involved in this process, since knockout (KO) mice lacking each of the three functional subunits of DNA-PK responded normally to CpG DNA. 

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in this process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "since"

Phrase: "knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560617:knock out [Injury or Poisoning]
  1000   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(KO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560617:knock out [Injury or Poisoning]
  1000   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "each of the three functional subunits of DNA-PK"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205245:Functional [Functional Concept]
   739   C0205449:Three [Quantitative Concept]
   739   C0542341:Functional [Functional Concept]
   739   C0851827:Dependent [Qualitative Concept]
   739   C1457900:Each [Quantitative Concept]
   739   C1701901:Dependent [Qualitative Concept]
   739   C2700217:Functional [Conceptual Entity]
   739   C3244310:dependent [Functional Concept]
   706   C1711351:Subunit [Quantitative Concept]

Phrase: "responded"

Phrase: "normally to CpG DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.28: These findings support a model in which one or more members of the wortmannin-sensitive PI3-kinase family facilitate the interaction of CpG DNA with TLR-9 in endocytic vesicles, thereby triggering immune activation.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a model in which one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "or"

Phrase: "more members of the wortmannin-sensitive PI3-kinase family"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   754   C0086282:Family Members [Family Group]
   738   C0680022:members [Population Group]
   737   C0812311:MEMBER 3 [Gene or Genome]
   737 E C1611821:Family Member [Intellectual Product]
   704 E C2698041:Member [Professional or Occupational Group]

Phrase: "facilitate"

Phrase: "the interaction of CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "in endocytic vesicles,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887883:Endocytic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "thereby"

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "immune activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]
Processing 00000000.tx.29: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Mice. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.30: Female C57BL/6 mice (610-wk old) were obtained from The Jackson Laboratory while DNA-PKcs-/- and Ku70-/- were obtained from Frederick Alt (Harvard Medical School, Boston, MA; references 19 and 20). 

Phrase: "Female C57BL/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   912   C1521751:C57BL/6 Mouse [Mammal]
   875   C0025921:Mice, C57BL [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(610-wk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "obtained from The Jackson Laboratory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1301820:Obtained [Functional Concept]
   760   C3244292:laboratory [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "while"

Phrase: "DNA-PKcs-/-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Ku70-/-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705873:Ku70 [Gene or Genome]
  1000   C1823878:Ku70 [Gene or Genome]

Phrase: "were"

Phrase: "obtained from Frederick Alt (Harvard Medical School,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   748   C0036375:School [Manufactured Object,Organization]
   748   C0205476:Medical [Functional Concept]
   748   C1301820:Obtained [Functional Concept]
   728   C0151905:ALT INCREASED [Finding]
   714 E C1706701:Obtain [Activity]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ";"

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "19"

Phrase: "and"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.31: Ku80-/- mice were generated as described previously (21). 

Phrase: "Ku80-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.32: All studies were approved by the CBER Animal Care and Use Committee. 

Phrase: "All studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "approved by the CBER Animal Care"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0178478:animal care [Occupation or Discipline]
   753   C0003062:Animal [Animal]
   753   C0205540:Approved [Qualitative Concept]
   753   C1947933:Care [Activity]
   753   C2826367:CBER [Professional or Occupational Group]

Phrase: "and"

Phrase: "Use Committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.33: Reagents. 

Phrase: "Reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.34: Genomic DNA from E. coli and calf thymus, LPS, and wortmannin were obtained from Sigma-Aldrich. 

Phrase: "Genomic DNA from E. coli"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017428:Genomic [Gene or Genome]
   760   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "calf thymus,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0040113:Thymus [Body Part, Organ, or Organ Component]
   861   C1015036:Thymus [Plant]
   861   C1515430:THYMUS [Tissue]
   805 E C1306748:Thymus gland [Body Part, Organ, or Organ Component]

Phrase: "LPS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "and"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "were"

Phrase: "obtained from Sigma-Aldrich."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1719918:Sigma [Intellectual Product]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.35: Genomic DNA was repurified by treatment with Triton-X114 to remove LPS as described previously (22). 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "repurified by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with Triton-X114 to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.36: Single-stranded DNA was prepared by heat denaturing double-stranded DNA at 95C for 5 min followed by immediate cooling on ice. 

Phrase: "Single-stranded DNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0012935:DNA, Single-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   865   C1979975:Single strand [Qualitative Concept]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   755   C1704972:Strand [Spatial Concept]
   755   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared by heat denaturing double-stranded DNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0018837:Heat [Natural Phenomenon or Process]
   748   C0205173:Double [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714   C1521827:Prepare [Functional Concept]

Phrase: "at 95C"

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by immediate cooling"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0205253:Immediate [Temporal Concept]
   770   C0205548:Immediate [Temporal Concept]
   770   C0678568:cooling [Natural Phenomenon or Process]
   737 E C1548792:Cool [Qualitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.37: Phosphorothioate, Cy3-, and FITC-labeled oligodeoxynucleotides (ODNs) were synthesized at the CBER core facility. 

Phrase: "Phosphorothioate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599533:phosphorothioate [Inorganic Chemical]

Phrase: "Cy3-,"

Phrase: "and"

Phrase: "FITC-labeled oligodeoxynucleotides (ODNs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized at the CBER core facility."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   753   C0444669:Core [Spatial Concept]
   753   C1167518:core [Cell Component]
   753   C1547538:Facility [Idea or Concept]
   753   C1706352:Core [Medical Device]
   753   C1882467:Core [Manufactured Object]
   753   C1883254:Synthesized [Activity]
   753   C2826367:CBER [Professional or Occupational Group]
   753   C3274653:Core [Body Substance]
Processing 00000000.tx.38: The sequence of the ODNs used in this work are: CpG ODN1555; 

Phrase: "The sequence of the ODNs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "used in this work"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "CpG ODN1555"

Phrase: ";"
Processing 00000000.tx.39: GCTAGACGTTAGCGT, CpG ODN1466; 

Phrase: "GCTAGACGTTAGCGT,"

Phrase: "CpG ODN1466"

Phrase: ";"
Processing 00000000.tx.40: TCAACGTTGA, human CpG ODNK3; 

Phrase: "TCAACGTTGA,"

Phrase: "human CpG ODNK3"

Phrase: ";"
Processing 00000000.tx.41: ATCGACTCTCGAGCGTTCTC, control ODN1612; 

Phrase: "ATCGACTCTCGAGCGTTCTC,"

Phrase: "control ODN1612"

Phrase: ";"
Processing 00000000.tx.42: GCTAGATGTTAGCGT, control ODN1471; 

Phrase: "GCTAGATGTTAGCGT,"

Phrase: "control ODN1471"

Phrase: ";"
Processing 00000000.tx.43: TCAAGCTTGA, and human control ODNK10; 

Phrase: "TCAAGCTTGA,"

Phrase: "and"

Phrase: "human control ODNK10"

Phrase: ";"
Processing 00000000.tx.44: ATGCACTCTGCAGGCTTCTC (9, 23). 

Phrase: "ATGCACTCTGCAGGCTTCTC"

Phrase: "(9,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: Less than 0.01 U/g of endotoxin was present in any DNA used in this work, as determined by Limulus amebocyte lysate (LAL) assay (Bio-Whittaker). 

Phrase: "Less than 0.01 U/g of endotoxin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0439092:Less Than [Intellectual Product]
           less
   770   C1532633:U/g [Quantitative Concept]
   770   C2608091:U/g [Quantitative Concept]
   744   C0014264:Endotoxin [Carbohydrate,Hazardous or Poisonous Substance,Lipid]
   744   C0439267:g% [Quantitative Concept]
   744   C0547044:Less [Qualitative Concept]

Phrase: "was"

Phrase: "present in any DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "used in this work,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "determined by Limulus amebocyte lysate (LAL) assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0059289:amoebocyte lysate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0023721:Limulus [Eukaryote]
   753   C0031307:amebocyte [Cell]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1881488:Lysate [Physical Object]

Phrase: "(Bio-Whittaker"

Phrase: ")."
Processing 00000000.tx.46: Cell Transfection and Luciferase Assay. 

Phrase: "Cell Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Luciferase Assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.47: HEK-293 (5 x 104) cells (American Type Culture Collection) were transfected with 0.8 g of vector plasmid (pCIneo; Promega), pCIneo-hTLR9, or pCIneo-hTLR4 (9) plus 0.1 g of p5xNF-B-luc (Stratagene) and 0.1 g of pSV--galactosidase (Promega) and incubated for 24 h at 37C. 

Phrase: "HEK-293"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0812263:HEK [Gene or Genome]
   861   C1704817:HEK [Gene or Genome]

Phrase: "(5 x 104"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(American Type Culture Collection"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "transfected with 0.8 g of vector plasmid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1514152:Plasmid Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0439267:g% [Quantitative Concept]
   744   C0442335:Vector [Spatial Concept]
   744   C1705099:Vector [Idea or Concept]

Phrase: "(pCIneo"

Phrase: "; Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "pCIneo-hTLR9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0962445:hTLR9 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "pCIneo-hTLR4"

Phrase: "(9"

Phrase: ")"

Phrase: "plus 0.1 g of p5xNF-B-luc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   744   C0439267:g% [Quantitative Concept]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "and"

Phrase: "0.1 g of pSV--galactosidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.48: The cells were then stimulated with ODNs or LPS for 24 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with ODNs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "LPS for 24 h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023810:LPS [Lipid]
   770   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   770   C2697656:LPS [Gene or Genome]
Processing 00000000.tx.49: Luciferase assays were performed according to the manufacturer's instructions (Promega). 

Phrase: "Luciferase assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed according to the manufacturer's instructions"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.50: -galactosidase activity was used to normalize the values. 

Phrase: "-galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150051:galactosidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.51: Flow Cytometric Analysis of Cell Surface Molecule Expression. 

Phrase: "Flow Cytometric Analysis of Cell Surface Molecule Expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   731   C1513380:Molecular Analysis [Molecular Biology Research Technique]
Processing 00000000.tx.52: In brief, ODN-stimulated cells were washed with PBS, fixed with 4% paraformaldehyde for 5 min at 37C, and stained with FITC- or PE-labeled Abs in the presence of anti-CD16 Ab for 30 min at room temperature (22). 

Phrase: "In brief, ODN-stimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "stained with FITC-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "PE-labeled Abs in the presence of anti-CD16 Ab"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.53: Stained cells were washed, resuspended in PBS/0.1% BSA plus azide, and analyzed by FACSortTM (BD Biosciences). 

Phrase: "Stained cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "resuspended in PBS/0.1% BSA plus azide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004492:azide [Chemical Viewed Structurally]
   744   C0332287:Plus [Qualitative Concept]
   744   C1720830:PBS [Disease or Syndrome]
   744   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "analyzed by FACSortTM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "(BD Biosciences"

Phrase: ")."
Processing 00000000.tx.54: Abs specific for the following molecules were obtained from BD PharMingen: CD11c; 

Phrase: "Abs"

Phrase: "specific for the following molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "obtained from BD PharMingen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: ":"

Phrase: "CD11c"

Phrase: ";"
Processing 00000000.tx.55: CD40; 

Phrase: "CD40"

Phrase: ";"
Processing 00000000.tx.56: CD80; 

Phrase: "CD80"

Phrase: ";"
Processing 00000000.tx.57: and CD86. 

Phrase: "and"

Phrase: "CD86."
Processing 00000000.tx.58: Cytokine-specific ELISA. 

Phrase: "Cytokine-specific ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.59: Immulon 2 microtiter plates (96-well) were coated with antiIL-12 (BD PharMingen) in PBS for 4 h. 

Phrase: "Immulon 2 microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1709027:Microtiter Plate [Research Device]
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "(96-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "coated with antiIL-12"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(BD PharMingen"

Phrase: ")"

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.60: After the plates were blocked and washed, supernatants from stimulated cells were added for 2 h at room temperature. 

Phrase: "After the plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "washed, supernatants from stimulated cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "added for 2 h"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   802   C0947272:Add 2 [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.61: The plates were then washed and treated with biotinylated anticytokine Ab followed by phosphatase-streptavidin (BD PharMingen) as described previously (22). 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "treated with biotinylated anticytokine Ab"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "followed by phosphatase-streptavidin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   770   C1149880:phosphatase [Molecular Function]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(BD PharMingen"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.62: A standard curve generated using recombinant IL-12 was used to determine cytokine concentration. 

Phrase: "A standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant IL-12"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C1149217:IL-12 [Molecular Function]
   901   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0020898:IL [Geographic Area]
   827   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0022271:IL [Geographic Area]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "cytokine concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.63: CpG ODN Internalization. 

Phrase: "CpG ODN Internalization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871786:internalization [Mental Process]
   734   C0914671:CPG-ODN [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.64: Cells were incubated with 13 M FITC-labeled ODN plus 1 M wortmannin at 37C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with 13 M FITC-labeled ODN plus 1 M wortmannin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   738   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   738   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C0332287:Plus [Qualitative Concept]
   738   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0441923:M+ [Intellectual Product]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1708632:Labeled [Qualitative Concept]
   704 E C0181496:Label [Manufactured Object]
   704 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "at 37C."
Processing 00000000.tx.65: Cells were washed after 1 h, and surface-bound FITC was quenched by trypan blue (1:4 dilution; 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed after 1 h,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "surface-bound FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "quenched by trypan blue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1260957:Blue [Qualitative Concept]
   770   C1565627:Trypan [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.66: Sigma-Aldrich). 

Phrase: "Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.67: Internalized FITC was quantified by FACSortTM (BD Biosciences) as described previously (24). 

Phrase: "Internalized FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "quantified by FACSortTM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.68: Confocal Microscopy. 

Phrase: "Confocal Microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.69: HEK-293 cells that had been stably transfected with human TLR-9 fused with HA (9) were incubated with Cy3-labeled ODN for 10120 min at 37C. 

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "stably"

Phrase: "transfected with human TLR-9"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1309709:Toll-Like Receptor 9, human [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
           Toll-Like Receptor 9
   853   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   853   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   814   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0086418:Human [Human]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   748   C1336636:TOLL [Gene or Genome]
   748   C1705581:TOLL [Gene or Genome]

Phrase: "fused with HA (9"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0699952:Fused [Functional Concept]
   737 E C1414861:FUSE [Gene or Genome]
   737 E C1708111:Fuse [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "incubated with Cy3-labeled ODN"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "for 10120 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.70: Cells were washed, fixed, permeabilized, and stained with FITCanti-HA Ab (clone 3F10; Roche Laboratories). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: ","

Phrase: "permeabilized"

Phrase: ","

Phrase: "and"

Phrase: "stained with FITCanti-HA Ab (clone 3F10"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0009013:Clone [Cell]
   748   C1522642:Clone [Tissue]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "; Roche Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.71: The subcellular localization of Cy3 and FITC signals was determined by confocal microscopy (LSM5 PASCAL; Carl Zeiss).  

Phrase: "The subcellular localization of Cy3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "FITC signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "determined by confocal microscopy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]

Phrase: "(LSM5 PASCAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439473:pascal [Quantitative Concept]

Phrase: "; Carl Zeiss"

Phrase: ")."
Processing 00000000.tx.72: Results Top Abstract Introduction Materials and Methods Results Discussion References  CpG DNAinduced Immune Activation Is Independent of DNA-PK. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "CpG DNAinduced Immune Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "Is Independent of DNA-PK."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332291:Independent of [Functional Concept]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085862:Independent [Idea or Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1299583:Independent [Finding]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.73: It was previously reported that DNA-PK plays a critical role in mediating CpG DNAdependent immune activation (10). 

Phrase: "It"

Phrase: "was"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "CpG DNAdependent immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.74: To confirm that finding, we examined the response of three different strains of KO mice, each lacking a different functional subunit of DNA-PK (DNA-PKcs, Ku70, and Ku80) to various CpG motifs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the response of three different strains of KO mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "each"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "a different functional subunit of DNA-PK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   744   C0205245:Functional [Functional Concept]
   744   C0542341:Functional [Functional Concept]
   744   C1711351:Subunit [Quantitative Concept]
   744   C2700217:Functional [Conceptual Entity]

Phrase: "(DNA-PKcs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Ku70,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705873:Ku70 [Gene or Genome]
  1000   C1823878:Ku70 [Gene or Genome]

Phrase: "and"

Phrase: "Ku80"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337034:Ku80 [Gene or Genome]
  1000   C1710692:Ku80 [Gene or Genome]

Phrase: ")"

Phrase: "to various CpG motifs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.75: These animals had no mature T or B cells, as expected for the KO phenotype (1921 and unpublished data). 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "no mature T"

Phrase: "or"

Phrase: "B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "expected for the KO phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1517001:Expected [Idea or Concept]
   760   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(1921"

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.76: PCR analyses confirmed that the relevant DNA-PK genes were disrupted in these animals (unpublished data). 

Phrase: "PCR analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0200931:PCR analysis [Laboratory Procedure]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the relevant DNA-PK genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   836   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "disrupted in these animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.77: When spleen cells from the KO mice were stimulated with bacterial DNA or CpG ODNs (both phosphodiester and phosphorothioate), their IL-12, IL-6, and IFN- responses did not differ significantly from wild-type mice (Fig. 1 and unpublished data). 

Phrase: "When"

Phrase: "spleen cells from the KO mice"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C1519474:Mouse Spleen [Tissue]
   753   C0007634:Cells [Cell]
   753   C0037993:Spleen [Body Part, Organ, or Organ Component]
   753   C0771377:SPLEEN [Tissue]
   753   C1278932:Spleen [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with bacterial DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0521009:Bacterial [Qualitative Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "CpG ODNs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "both phosphodiester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599124:phosphodiester [Organophosphorus Compound]

Phrase: "and"

Phrase: "phosphorothioate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599533:phosphorothioate [Inorganic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "their IL-12,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149217:IL-12 [Molecular Function]
  1000   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "IL-6,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334122:IL6 [Gene or Genome]
  1000   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "IFN- responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly from wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.78: Similarly, bone marrowderived DCs (BMDCs) from these mice underwent normal cellular maturation (characterized by the upregulation of CD40, CD80, and CD86) when stimulated with CpG DNA (Fig. 1 and unpublished data). 

Phrase: "Similarly,"

Phrase: "bone marrowderived DCs (BMDCs) from these mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0268238:DCS [Disease or Syndrome]

Phrase: "underwent"

Phrase: "normal cellular maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678723:Maturation [Organism Function]
   827   C0870861:maturation [Phenomenon or Process]
   827   C1254042:Maturation [Physiologic Function]

Phrase: "("

Phrase: "characterized by the upregulation of CD40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]
   753   C1880022:Characterized [Activity]

Phrase: "CD80,"

Phrase: "and"

Phrase: "CD86"

Phrase: ")"

Phrase: "when"

Phrase: "stimulated with CpG DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.79: Thus, in contrast to the results reported by Chu et al. we found no deficit in the immune response of DNA-PK KO mice to CpG motifs. 

Phrase: "Thus,"

Phrase: "in contrast to the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reported by Chu et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no deficit in the immune response of DNA-PK KO mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0162429:Deficit, NOS [Disease or Syndrome]
   736   C2987487:Deficit [Qualitative Concept]

Phrase: "to CpG motifs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.80: View larger version (29K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.81: CpG DNAinduced cytokine production and BMDC maturation are independent of DNA-PK. 

Phrase: "CpG DNAinduced cytokine production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1327413:cytokine production [Organism Function]
   812   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "BMDC maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "are independent of DNA-PK."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332291:Independent of [Functional Concept]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085862:Independent [Idea or Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1299583:Independent [Finding]
   753   C1551058:Are [Quantitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.82: Spleen cells (2.5 x 106 cells/ml) or BMDCs (5 x 105 cells/ml) from DNA-PKcs-/-, Ku70-/-, Ku80 -/-, and wild-type mice were incubated with 50 g/ml of calf thymus (CT) or E. coli (EC) DNA, 1 M for phosphorothioate ODNs, or 10 M of phosphodiester ODNs (PO) for 48 h. 

Phrase: "Spleen cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0007634:Cells [Cell]
   861   C0037993:Spleen [Body Part, Organ, or Organ Component]
   861   C0771377:SPLEEN [Tissue]
   861   C1278932:Spleen [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(2.5 x 106 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2699156:Cells/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "BMDCs (5 x 105 cells/ml)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C2699156:Cells/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]
   711   C0222677:Bone cells [Cell]

Phrase: "from DNA-PKcs-/-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Ku70-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705873:Ku70 [Gene or Genome]
  1000   C1823878:Ku70 [Gene or Genome]

Phrase: "Ku80 -/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337034:Ku80 [Gene or Genome]
  1000   C1710692:Ku80 [Gene or Genome]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 50 g/ml of calf thymus (CT)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0040113:Thymus [Body Part, Organ, or Organ Component]
   744   C0230445:Calf [Body Location or Region]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1015036:Thymus [Plant]
   744   C1305418:Calf [Body Part, Organ, or Organ Component]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1515430:THYMUS [Tissue]
   739   C0772201:Thymus Gland-Calf [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "E. coli (EC) DNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0014834:E coli [Bacterium]

Phrase: "1 M for phosphorothioate ODNs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "10 M of phosphodiester ODNs (ODNs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.83: IL-12 levels in culture supernatants were measured by ELISA, while the percentage of mature DCs (expressing high levels of both CD11c and CD40) was evaluated by FACS. 

Phrase: "IL-12 levels in culture supernatants"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by ELISA,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "while"

Phrase: "the percentage of mature DCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "("

Phrase: "expressing"

Phrase: "high levels of both CD11c"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "CD40"

Phrase: ")"

Phrase: "was"

Phrase: "evaluated by FACS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.84: Data represent the average  SD of the samples from three mice per group.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average  SD of the samples"

Phrase: "from three mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.85: CpG DNAinduced Immune Activation Is Wortmannin Dependent. 

Phrase: "CpG DNAinduced Immune Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "Is"

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "Dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.86: Chu's finding that wortmannin could inhibit CpG DNAinduced immune activation was then examined. 

Phrase: "Chu's"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "could"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "CpG DNAinduced immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.87: BMDCs were isolated from wild-type and DNA-PKcs KO mice and stimulated with CpG ODN, bacterial DNA, LPS, or double-stranded RNA. 

Phrase: "BMDCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0268238:DCS [Disease or Syndrome]

Phrase: "were"

Phrase: "isolated from wild-type"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0205409:Isolated [Functional Concept]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "DNA-PKcs KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "stimulated with CpG ODN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0914671:CPG-ODN [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "bacterial DNA,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "LPS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "or"

Phrase: "double-stranded RNA."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   865   C1979882:Double strand [Qualitative Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205173:Double [Functional Concept]
   827   C1705764:Double [Activity]
   827   C1705765:Double [Qualitative Concept]
   755   C1704972:Strand [Spatial Concept]
   755   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.88: Wortmannin significantly inhibited CpG-induced cytokine production and BMDC maturation by cells isolated from both wild-type and KO mice (Fig. 2 and unpublished data). 

Phrase: "Wortmannin significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "CpG-induced cytokine production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1327413:cytokine production [Organism Function]
   812   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "BMDC maturation by cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1516349:Cell Maturation [Cell Function]
   770   C0678723:Maturation [Organism Function]
   770   C0870861:maturation [Phenomenon or Process]
   770   C1254042:Maturation [Physiologic Function]

Phrase: "isolated from both wild-type"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0205409:Isolated [Functional Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206745:Knock-out Mice [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.89: In contrast, wortmannin had no effect on the immune activation induced by LPS or double-stranded RNA (Fig. 2 and unpublished data). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "had"

Phrase: "no effect on the immune activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "induced by LPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023810:LPS [Lipid]
   790   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   790   C0205263:Induced [Functional Concept]
   790   C2697656:LPS [Gene or Genome]

Phrase: "or"

Phrase: "double-stranded RNA (Fig. 2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205173:Double [Functional Concept]
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C1705764:Double [Activity]
   804   C1705765:Double [Qualitative Concept]
   804   C1979882:Double strand [Qualitative Concept]
   733   C1704972:Strand [Spatial Concept]
   733   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.90: These findings confirm that DNA-PK was not involved in CpG-induced immune activation, and suggest some other wortmannin-sensitive molecule (presumably a different member of the wortmannin-sensitive PI3-kinase family) plays a crucial role in mediating CpG-dependent immune activation. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in CpG-induced immune activation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205263:Induced [Functional Concept]
   753   C0439662:Immune [Functional Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "some other wortmannin-sensitive molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "(presumably"

Phrase: "a different member of the wortmannin-sensitive PI3-kinase family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0086282:Family member [Family Group]
   751   C0812311:MEMBER 3 [Gene or Genome]
   751   C1611821:Family Member [Intellectual Product]
   736   C0680022:member [Population Group]
   736   C2698041:Member [Professional or Occupational Group]

Phrase: ")"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "CpG-dependent immune activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]
Processing 00000000.tx.91: View larger version (23K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.92: Wortmannin inhibits IL-12 production by CpG DNA in both wild-type and DNA-PKcs KO mice. 

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IL-12 production by CpG DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1819439:IL-12 production [Organism Function]
   753   C0033268:production [Occupational Activity]

Phrase: "in both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "DNA-PKcs KO mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.93: The effect of wortmannin on the production of IL-12 by BMDCs from both wild-type and DNA-PKcs-/- mice was evaluated as described in the legend to Fig. 

Phrase: "The effect of wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of IL-12"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149217:IL-12 [Molecular Function]
  1000   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "by BMDCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0268238:DCS [Disease or Syndrome]

Phrase: "from both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "DNA-PKcs-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: Additional controls include double-stranded RNA (Poly IC, 50 g/ml) and LPS (1 g/ml). 

Phrase: "Additional controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "double-stranded RNA (Poly IC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0032414:poly IC [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   717   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "50 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "LPS (1 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.96: Data represent the average  SD of three mice per group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average  SD of three mice"

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.97: *P < 0.01.  

Phrase: "*P < 0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.98: Effect of Wortmannin on CpG ODN Uptake. 

Phrase: "Effect of Wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on CpG ODN Uptake."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0914671:CPG-ODN [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.99: The mechanism by which wortmannin inhibited CpG-dependent immune activation was then examined. 

Phrase: "The mechanism by which wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "CpG-dependent immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.100: The interaction of CpG DNA with TLR-9 triggers a signaling cascade involving the rapid upregulation of NF-B and the subsequent production of immunostimulatory cytokines and chemokines (9, 23, 25). 

Phrase: "The interaction of CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "a signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2611812:signaling cascade [Cell Function]
   861   C1707310:Cascade [Manufactured Object]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the rapid upregulation of NF-B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "and"

Phrase: "the subsequent production of immunostimulatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1327413:cytokine production [Organism Function]
   753   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(9,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.101: To monitor this activity, HEK-293 cells were transiently transfected in vitro with a TLR-9encoding plasmid (pCIneo-TLR-9) plus a NF-Bdependent luciferase reporter construct (p5xNF-B-luc). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "this activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected"

Phrase: "in vitro with a TLR-9encoding plasmid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]

Phrase: "(pCIneo-TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   937   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   937   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   884   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   804   C1336636:TOLL [Gene or Genome]
   804   C1705581:TOLL [Gene or Genome]

Phrase: ")"

Phrase: "plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "a NF-Bdependent luciferase reporter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2827421:Construct [Classification]

Phrase: "(p5xNF-B-luc"

Phrase: ")."
Processing 00000000.tx.102: Consistent with previous findings, transfected cells stimulated with CpG (but not control) ODNs increased luciferase activity by more than ninefold (P < 0.01, Fig. 3 and reference 9). 

Phrase: "Consistent with previous findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with CpG ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "ODNs increased luciferase activity by more"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1151115:luciferase activity [Molecular Function]
   783   C0474395:increased activity [Finding]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "than ninefold"

Phrase: "(P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "reference 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.103: Wortmannin reduced this NF-Bmediated increase in luciferase expression in a dose-dependent manner (P < 0.01, Fig. 3). 

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "this NF-Bmediated increase in luciferase expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.104: This effect of wortmannin was CpG specific, since HEK-293 cells cotransfected with the luciferase reporter plus a TLR-4encoding plasmid (which confers responsiveness to LPS) responded normally to LPS stimulation in the presence of wortmannin (Fig. 3). 

Phrase: "This effect of wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "CpG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "since"

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cotransfected with the luciferase reporter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0335038:Reporter [Professional or Occupational Group]
   760   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   760   C1705915:Reporter [Conceptual Entity]
   760   C1709908:Reporter [Group]

Phrase: "plus a TLR-4encoding plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "which"

Phrase: "confers"

Phrase: "responsiveness to LPS)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205342:Responsive [Functional Concept]

Phrase: "responded"

Phrase: "normally to LPS stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023810:LPS [Lipid]
   770   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
   770   C2697656:LPS [Gene or Genome]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: These findings are consistent with a wortmannin-sensitive PI3-kinase contributing to the signaling process by which CpG DNA activates NF-B. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with a wortmannin-sensitive PI3-kinase contributing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "to the signaling process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3537152:signaling process [Biologic Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "by which CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NF-B."
Processing 00000000.tx.106: View larger version (29K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.107: Wortmannin selectively inhibits CpG-induced NF-B activation. 

Phrase: "Wortmannin selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "CpG-induced NF-B activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]
Processing 00000000.tx.108: HEK 293 (5 x 104) cells were transfected with plasmids encoding hTLR-9 or hTLR-4 plus p5xNF-B-luciferase. 

Phrase: "HEK 293"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0812263:HEK [Gene or Genome]
   861   C1704817:HEK [Gene or Genome]

Phrase: "(5 x 104"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "hTLR-9"

Phrase: "or"

Phrase: "hTLR-4 plus p5xNF-B-luciferase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.109: Cells were stimulated the next day with 1 M of CpG (K3), control (K10) ODN, or 1 g/ml of LPS in the presence or absence of wortmannin (WT). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the next day with 1 M of CpG (K3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0332173:/day [Temporal Concept]
   742   C0439228:day [Temporal Concept]
   742   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(K10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416714:K10 [Gene or Genome]

Phrase: ")"

Phrase: "ODN,"

Phrase: "or"

Phrase: "1 g/ml of LPS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1300565:g/mL [Quantitative Concept]
   797 E C1637390:mL/g [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of wortmannin (WT)."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.110: The increase in luciferase activity at 24 h is shown. 

Phrase: "The increase in luciferase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "at 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.111: Results represent the average  SD of triplicate cultures in experiments that were repeated three times. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average  SD of triplicate cultures"

Phrase: "in experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.112: *P < 0.05, **P < 0.01.  

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P < 0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.113: To further clarify the nature of this contribution, the uptake and localization of CpG DNA was monitored by confocal microscopy. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the nature of this contribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "localization of CpG DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "monitored by confocal microscopy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.114: HEK-293 cells were stably transfected with an HA-tagged TLR-9 construct, and then incubated with Cy-3labeled CpG ODN (red) and then stained with anti-HA Ab (green). 

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with an HA-tagged TLR-9 construct,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   806   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   806   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   782   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   739   C1336636:TOLL [Gene or Genome]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1705581:TOLL [Gene or Genome]
   739   C1708632:Tagged [Qualitative Concept]
   739   C2827421:Construct [Classification]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with Cy-3labeled CpG ODN ("
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0914671:CPG-ODN [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0010622:CY [Geographic Area]
   753   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332298:CY [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with anti-HA Ab (green"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332583:Green [Qualitative Concept]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.115: As seen in Fig. 

Phrase: "As"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.116: 4, CpG ODNs readily entered transfected cells and colocalized in endocytic vesicles with HA-tagged TLR-9. 

Phrase: "4,"

Phrase: "CpG ODNs readily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "entered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521975:Entered [Qualitative Concept]
   966 E C1522196:ENTER [Functional Concept]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "colocalized in endocytic vesicles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0887883:Endocytic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "with HA-tagged TLR-9."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   861   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   799   C1336636:TOLL [Gene or Genome]
   799   C1705581:TOLL [Gene or Genome]
Processing 00000000.tx.117: This interaction triggered the activation of NF-B and the production of immunostimulatory cytokines such as IL-8 (Fig. 3 and unpublished data). 

Phrase: "This interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "the activation of NF-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "the production of immunostimulatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1327413:cytokine production [Organism Function]
   760   C0033268:production [Occupational Activity]

Phrase: "such as IL-8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079633:IL 8 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.118: However, when transfected cells were treated with wortmannin, both the size and number of endocytic vesicles containing CpG ODNs plus TLR-9 decreases significantly, as did NF-B activation (Figs. 3 and 4). 

Phrase: "However,"

Phrase: "when"

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with wortmannin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "both"

Phrase: "the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "number of endocytic vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "CpG ODNs plus TLR-9 decreases significantly,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   791   C0547047:decreases [Quantitative Concept]
   758 E C0392756:Decrease [Qualitative Concept]

Phrase: "as"

Phrase: "did"

Phrase: "NF-B activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "(Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.119: These findings suggest that wortmannin interferes with the endosomal uptake and/or colocalization of CpG ODNs with TLR-9 in target cells. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "interferes with the endosomal uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0521102:Interferes with [Qualitative Concept]
           Interfere
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "and/or"

Phrase: "colocalization of CpG ODNs"

Phrase: "with TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "in target cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.120: View larger version (68K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(68K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.121: Wortmannin reduces the size and number of vesicles containing CpG ODN plus TLR-9. 

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "reduces"

Phrase: "the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "number of vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "CpG ODN plus TLR-9."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   877   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   877   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   845   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   795   C1336636:TOLL [Gene or Genome]
   795   C1705581:TOLL [Gene or Genome]
Processing 00000000.tx.122: HEK-293 cells were transfected HA-tagged TLR-9, and cultured with 1 M of wortmannin plus Cy3 (red) labeled CpG ODN (K3) for 2 h. 

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "HA-tagged TLR-9,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   861   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   799   C1336636:TOLL [Gene or Genome]
   799   C1705581:TOLL [Gene or Genome]

Phrase: "and"

Phrase: "cultured with 1 M of wortmannin plus Cy3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   744   C0332287:Plus [Qualitative Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711   C2242979:Culture [Laboratory Procedure]

Phrase: "(red) labeled CpG ODN (K3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1416740:K3 [Gene or Genome]
   804   C2825157:K3 [Quantitative Concept]

Phrase: ")"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.123: Cells were then fixed, stained with FITC-labeled anti-HA Ab (green), and analyzed by confocal microscopy. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: ","

Phrase: "stained with FITC-labeled anti-HA Ab (green"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332583:Green [Qualitative Concept]
   744   C1708632:Labeled [Qualitative Concept]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "analyzed by confocal microscopy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.124: The top panel shows the 3-dimensional stacked pictures of 15 sections with 0.8-m thickness and the bottom panel shows the representative section of the cells treated with CpG ODNs alone. 

Phrase: "The top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the 3-dimensional stacked pictures of 15 sections"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441469:pictures [Manufactured Object]
   711 E C0441468:picture [Manufactured Object]

Phrase: "with 0.8-m thickness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1280412:Thickness [Qualitative Concept]

Phrase: "and"

Phrase: "the bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the representative section of the cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205155:Section [Spatial Concept]
   753   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   753   C1522472:Section [Substance]
   753   C1552923:Section [Quantitative Concept]
   753   C1705191:Section [Physical Object]

Phrase: "treated with CpG ODNs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   816   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.125: Each panel is representative of multiple samples from repeat experiments.  

Phrase: "Each panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "is"

Phrase: "representative of multiple samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]

Phrase: "from repeat experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.126: To confirm this finding in cells that respond physiologically to CpG ODNs, the effect of wortmannin on the internalization of CpG ODNs and subsequent production of IL-12 by BMDCs was examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this finding in cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "respond"

Phrase: "physiologically to CpG ODNs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the effect of wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "of CpG ODNs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "subsequent production of IL-12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1819439:IL-12 production [Organism Function]
   760   C0033268:production [Occupational Activity]

Phrase: "by BMDCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0268238:DCS [Disease or Syndrome]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.127: As seen in Fig. 

Phrase: "As"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.128: 5, wortmannin reduced the internalization of CpG ODNs by 90% and the IL-12 response elicited by CpG ODNs by 85% (P < 0.01) when compared with baseline. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the internalization of CpG ODNs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "by 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "the IL-12 response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1149217:IL-12 [Molecular Function]
   734   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "elicited by CpG ODNs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0449265:Elicited by [Qualitative Concept]
           elicited
   816   C0914671:CpG oligodeoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by 85%"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "when"

Phrase: "compared with baseline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]
   790   C1707455:Compared [Activity]
Processing 00000000.tx.129: Similar results were obtained using BMDCs from DNA-PK KO mice, establishing that wortmannin inhibits ODN internalization in a DNA-PKindependent manner (unpublished data). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BMDCs from DNA-PK KO mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0268238:DCS [Disease or Syndrome]

Phrase: "establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "that wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ODN internalization in a DNA-PKindependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0871786:internalization [Mental Process]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.130: Taken together, these data strongly suggest that wortmannin-sensitive PI3-kinase(s) plays a critical role in the uptake and/or localization of CpG ODNs with TLR-9. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that wortmannin-sensitive PI3-kinase"

Phrase: "("

Phrase: "s)"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in the uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and/or"

Phrase: "localization of CpG ODNs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "with TLR-9."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]
Processing 00000000.tx.131: View larger version (20K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.132: CpG ODN internalization and subsequent activation of BMDCs is inhibited by wortmannin. 

Phrase: "CpG ODN internalization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871786:internalization [Mental Process]
   734   C0914671:CPG-ODN [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "subsequent activation of BMDCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "inhibited by wortmannin."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.133: (A) 106 BMDC/ml were incubated with FITC-labeled CpG ODN1555 plus 1 M of wortmannin. 

Phrase: "(A) 106 BMDC/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with FITC-labeled CpG ODN1555 plus 1 M of wortmannin."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   738   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   738   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C0332287:Plus [Qualitative Concept]
   738   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0441923:M+ [Intellectual Product]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1708632:Labeled [Qualitative Concept]
   704 E C0181496:Label [Manufactured Object]
   704 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.134: 60 min later cells were washed on ice and the signal from surface-bound FITC quenched using trypan blue. 

Phrase: "60 min later cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed on ice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "the signal from surface-bound FITC quenched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "trypan blue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1260957:Blue [Qualitative Concept]
   861   C1565627:Trypan [Organic Chemical]
Processing 00000000.tx.135: Internalized FITC was detected by FACS. 

Phrase: "Internalized FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "detected by FACS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: Data represent the mean fluorescein intensity ( SD) from three independently studied mice/group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean fluorescein intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0522510:Intensity [Qualitative Concept]

Phrase: "( SD) from three independently studied mice/group."
Processing 00000000.tx.137: *P < 0.01. 

Phrase: "*P < 0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.138: (B) BMDCs were treated as described in A for 48 h. 

Phrase: "(B) BMDCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0268238:DCS [Disease or Syndrome]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "described in A for 48 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1552738:described [Idea or Concept]
Processing 00000000.tx.139: IL-12 levels in culture supernatants were measured by ELISA. 

Phrase: "IL-12 levels in culture supernatants"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by ELISA."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.140: Data represent the averages  SD of IL-12 concentrations in four mice per group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the averages  SD of IL-12 concentrations"

Phrase: "in four mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.141: The experiment was repeated five times with similar results. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "five times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.142: *P < 0.01.   

Phrase: "*P < 0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.143: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  CpG motifs in bacterial DNA act as pathogen-associated molecular patterns, interacting with TLR-9 to induce a robust innate immune response (79). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "CpG motifs in bacterial DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3178798:DNA Motifs [Nucleotide Sequence]
   726   C1514562:Motif [Amino Acid Sequence]

Phrase: "act as pathogen-associated molecular patterns,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0332281:Associated [Qualitative Concept]
   753   C0449774:Patterns [Spatial Concept]
   753   C0450254:Pathogen [Organism]
   753   C1521991:Molecular [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "interacting with TLR-9 to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   853   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   853   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   814   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   748   C1336636:TOLL [Gene or Genome]
   748   C1705581:TOLL [Gene or Genome]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a robust innate immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0020969:Innate Immune Response [Organism Attribute,Pathologic Function]
   861   C0301872:Immune response [Organ or Tissue Function]
   812   C0439662:Immune [Functional Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.144: Previous studies established that CpG DNA and TLR-9 colocalize in endocytic vesicles and that cellular activation is associated with an increase in the size and number of these vesicles (9). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "colocalize in endocytic vesicles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0887883:Endocytic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "that cellular activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "number of these vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.145: The process involved in the uptake, transport, and colocalization of CpG DNA with TLR-9 have not been established. 

Phrase: "The process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "involved in the uptake,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "colocalization of CpG DNA"

Phrase: "with TLR-9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.146: Current results indicate that the internalization of CpG ODNs is wortmannin sensitive, suggesting that one or more members of the PI3-kinase family contribute to this process. 

Phrase: "Current results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the internalization of CpG ODNs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "is"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "sensitive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more members of the PI3-kinase family"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   762   C0086282:Family Members [Family Group]
   745   C0812311:MEMBER 3 [Gene or Genome]
   745 E C1611821:Family Member [Intellectual Product]
   742   C0680022:members [Population Group]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "contribute to this process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1522240:Process [Phenomenon or Process]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.147: Contrary to the conclusions in a previous report (10), we find that CpG-mediated immune activation is a DNA-PKindependent process. 

Phrase: "Contrary to the conclusions"

Phrase: "in a previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that CpG-mediated immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "a DNA-PKindependent process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.148: Supporting this conclusion is evidence that cells from DNA-PK KO mice (lacking functional DNA-PKcs, Ku70, or Ku80) internalize and respond normally to CpG DNA. 

Phrase: "Supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "this conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that cells from DNA-PK KO mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "functional DNA-PKcs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Ku70,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705873:Ku70 [Gene or Genome]
  1000   C1823878:Ku70 [Gene or Genome]

Phrase: "or"

Phrase: "Ku80"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337034:Ku80 [Gene or Genome]
  1000   C1710692:Ku80 [Gene or Genome]

Phrase: ")"

Phrase: "internalize"

Phrase: "and"

Phrase: "respond"

Phrase: "normally to CpG DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.149: PCR analyses confirmed that the relevant DNA-PK genes were disrupted in these KO mice. 

Phrase: "PCR analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0200931:PCR analysis [Laboratory Procedure]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the relevant DNA-PK genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   836   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "disrupted in these KO mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0206745:Knock-out Mice [Mammal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332454:Disrupted [Qualitative Concept]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1522225:Knock-out [Experimental Model of Disease]
Processing 00000000.tx.150: In addition, phenotypic studies established that the expected abnormalities in T and B cell maturation/function were present in these animals. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "phenotypic studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the expected abnormalities in T"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "and"

Phrase: "B cell maturation/function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   875   C0007613:Cell Function [Cell Function]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "were"

Phrase: "present in these animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.151: Results shown in Figs. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Figs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   756 E C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.152: 1 and 2 are inconsistent with those of Chu et al. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "are"

Phrase: "inconsistent with those of Chu et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442809:Inconsistent [Qualitative Concept]
Processing 00000000.tx.153: (10), who reported that a different strain of DNA-PKcs KO mouse failed to produce cytokine when stimulated by CpG DNA. 

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "a different strain of DNA-PKcs KO mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0080194:Strain [Injury or Poisoning]
   742   C0456178:strain [Intellectual Product]
   742   C1518614:Strain [Organism]
   742   C2987481:Strain [Mental Process]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "when"

Phrase: "stimulated by CpG DNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.154: Unfortunately, that strain of DNA-PKcs KO mouse was unavailable, preventing our performing a comparative study of potential epigenetic differences. 

Phrase: "Unfortunately,"

Phrase: "that"

Phrase: "strain of DNA-PKcs KO mouse"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0206745:Knock-Out Mouse [Mammal]
   774   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0080194:Strain [Injury or Poisoning]
   748   C0456178:strain [Intellectual Product]
   748   C0560617:knock out [Injury or Poisoning]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1518614:Strain [Organism]
   748   C1522225:Knock-out [Experimental Model of Disease]
   748   C1701901:Dependent [Qualitative Concept]
   748   C2987481:Strain [Mental Process]
   748   C3244310:dependent [Functional Concept]
   732   C1513684:Mouse Strains [Mammal]

Phrase: "was"

Phrase: "unavailable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686905:Unavailable [Functional Concept]

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "our performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "a comparative study of potential epigenetic differences."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0009491:Comparative Study [Intellectual Product]
   778   C1579762:comparative study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.155: However, results from all three strains of DNA-PK KO mice used in this work strongly suggest that DNA-PK plays no role in mediating the immune response to CpG DNA. 

Phrase: "However,"

Phrase: "results from all three strains of DNA-PK KO mice"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   756   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0206745:Knock-out Mice [Mammal]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0080194:Strains [Injury or Poisoning]
   738   C0205449:Three [Quantitative Concept]
   738   C0456178:strains [Intellectual Product]
   738   C0560617:knock out [Injury or Poisoning]
   738   C0851827:Dependent [Qualitative Concept]
   738   C1274040:Result [Functional Concept]
   738   C1522225:Knock-out [Experimental Model of Disease]
   738   C1546471:Result [Idea or Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C2825142:Result [Finding]
   738   C3244310:dependent [Functional Concept]
   737   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1513684:Mouse Strains [Mammal]
   704 E C1518614:Strain [Organism]
   704 E C2987481:Strain [Mental Process]

Phrase: "used in this work strongly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0043227:Work [Occupational Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "no role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the immune response to CpG DNA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0301872:Immune response [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.156: Chu et al. also observed that wortmannin significantly reduced the immune activation triggered by CpG DNA and attributed this effect to the inhibition of DNA-PK function (10). 

Phrase: "Chu et al. also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that wortmannin significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "triggered by CpG DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1444748:Triggered by [Qualitative Concept]
           Trigger
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0032930:Trigger [Clinical Attribute]

Phrase: "and"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "this effect to the inhibition of DNA-PK function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.157: Our results exclude DNA-PK as the wortmannin-sensitive mediator of CpG DNAinduced cell stimulation (Fig. 2). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "DNA-PK as the wortmannin-sensitive mediator of CpG DNAinduced cell stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   735   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.158: Wortmannin blocks a conserved ATP-binding site located in the catalytic domain of many members of the PI3-kinase family. 

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "a conserved ATP-binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   861   C1148923:ATP binding [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "located in the catalytic domain of many members"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0600499:Catalytic Domain [Amino Acid Sequence]
   744   C0007382:Catalytic [Natural Phenomenon or Process]
   744   C0680022:members [Population Group]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the PI3-kinase family."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   853   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.159: Class I and III PI3-kinases facilitate phagocytosis, endocytosis, and endosomal maturation (1517). 

Phrase: "Class I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441885:Class I [Classification]
  1000   C2698967:Class I [Finding]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "III PI3-kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "facilitate"

Phrase: "phagocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:Phagocytosis [Cell Function]

Phrase: "endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "endosomal maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "(1517"

Phrase: ")."
Processing 00000000.tx.160: Our results suggest that wortmannin-sensitive PI3-kinases contribute to the internalization and/or transport of CpG ODNs to TLR-9containing endosomes. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that wortmannin-sensitive PI3-kinases"

Phrase: "contribute to the internalization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871786:internalization [Mental Process]
   770   C1880177:Contribute [Activity]

Phrase: "and/or"

Phrase: "transport of CpG ODNs to TLR-9containing endosomes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C1550030:Transport To [Idea or Concept]
   741   C1156042:endosome transport [Cell Function]
   739   C0005528:Transport, NOS [Cell Function]
   739   C1317949:Transport [Manufactured Object]
   739   C3495449:transport [Medical Device]
   716 E C3549360:endosomal transport [Cell Function]
Processing 00000000.tx.161: Consistent with such a model, it was recently shown that PI3-kinases are activated after CpG-mediated stimulation of DCs (26). 

Phrase: "Consistent with such"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "a model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "it"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PI3-kinases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "activated after CpG-mediated stimulation of DCs (26"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0268238:DCS [Disease or Syndrome]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1879547:Activated [Activity]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   711 E C1515877:Activate [Functional Concept]

Phrase: ")."
Processing 00000000.tx.162: Due to the large number and overlapping activities of members of the PI3-kinase family, additional studies are needed to identify the specific kinase(s) that contribute to CpG-mediated signaling. 

Phrase: "Due to the large number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "overlapping activities of members of the PI3-kinase family,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   783   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   759   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   754   C0814574:family activities [Social Behavior]
   738   C0441655:Activities [Activity]
   737   C1150423:kinase activity [Molecular Function]
   704 E C0205177:Activity [Functional Concept]
   704 E C0439167:% activity [Quantitative Concept]
   704 E C1561536:*Activity [Idea or Concept]

Phrase: "additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the specific kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "contribute to CpG-mediated signaling."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037083:Signaling [Cell Function]
   760   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1880177:Contribute [Activity]
   760   C3537152:signaling [Biologic Function]
Processing 00000000.tx.163: Indeed, wortmannin sensitivity does not unequivocally establish that PI3-kinases are involved in this process. 

Phrase: "Indeed,"

Phrase: "wortmannin sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "does"

Phrase: "not unequivocally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that PI3-kinases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "involved in this process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.164: However, considerable data (including results shown in Figs. 2 and 3) establish that the inhibitory effects of wortmannin are selective for PI3-kinases, having no impact on responses mediated by other members of the TLR family. 

Phrase: "However,"

Phrase: "considerable data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Figs. 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0349966:Figs [Food]
   737 E C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that"

Phrase: "the inhibitory effects of wortmannin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "selective for PI3-kinases,"

Phrase: "having"

Phrase: "no impact on responses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "mediated by other members of the TLR family."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   782   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0086282:Family Members [Family Group]
   741 E C1611821:Family Member [Intellectual Product]
   739   C0015576:Family [Family Group]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0680022:members [Population Group]
   739   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   739   C1336636:TOLL [Gene or Genome]
   739   C1704727:Family [Conceptual Entity]
   739   C1705581:TOLL [Gene or Genome]
   706 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.165: Taken together, the present findings strongly suggest that CpG DNAinduced innate immune activation is mediated through TLR-9 but not DNA-PK and that wortmannin-sensitive member(s) of the PI3-kinase family play a critical role in shuttling CpG DNA to TLR-9.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the present findings strongly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CpG DNAinduced innate immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "mediated through TLR-9"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   882   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   833   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   753   C1336636:TOLL [Gene or Genome]
   753   C1705581:TOLL [Gene or Genome]

Phrase: "but"

Phrase: "not DNA-PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that wortmannin-sensitive member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0680022:member [Population Group]
   827   C2698041:Member [Professional or Occupational Group]

Phrase: "("

Phrase: "s) of the PI3-kinase family"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinase
   744   C0015576:Family [Family Group]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C1704727:Family [Conceptual Entity]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C2603362:S' [Clinical Attribute]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in shuttling CpG DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "to TLR-9."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]
   923   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   812   C1336636:TOLL [Gene or Genome]
   812   C1705581:TOLL [Gene or Genome]
Processing 00000000.tx.166: Acknowledgments  We thank Drs. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.167: Daniela Verthelyi, Marina Zaitseva, Cevayir Coban, Takahiro Sugiyama, Li Dong, and Rainald Zeuner for critical review of this manuscript. 

Phrase: "Daniela Verthelyi,"

Phrase: "Marina Zaitseva,"

Phrase: "Cevayir Coban,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0917861:Coban [Antibiotic,Organic Chemical]

Phrase: "Takahiro Sugiyama,"

Phrase: "Li Dong,"

Phrase: "and"

Phrase: "Rainald Zeuner for critical review of this manuscript."
Processing 00000000.tx.168: We thank Henry Chen for technical support, and Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Henry Chen for technical support,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0999213:Chen [Bird]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.169: Fred Alt for providing Ku70 and Ku80 KO mice. 

Phrase: "Fred Alt for providing Ku70"

Phrase: "and"

Phrase: "Ku80 KO mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.170: This work was supported in part by a grant from the National Vaccine Program. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "from the National Vaccine Program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
Processing 00000000.tx.171: The assertions herein are the private ones of the authors and are not to be constructed as official or as reflecting the views of the Food and Drug Administration at large. 

Phrase: "The assertions herein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301625:Assertion [Qualitative Concept]

Phrase: "are"

Phrase: "the private ones of the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "constructed as official"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2347387:Official [Qualitative Concept]
   756   C2827421:Construct [Classification]

Phrase: "or as reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0558058:Reflecting [Mental Process]

Phrase: "the views of the Food and Drug Administration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449911:Views [Spatial Concept]

Phrase: "at large."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]
Processing 00000000.tx.172: Submitted: May 13, 2002 Accepted: June 3, 2002  References Top Abstract Introduction Materials and Methods Results Discussion References  Janeway, C.A., Jr., and R. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "May 13,"

Phrase: "2002"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "June 3,"

Phrase: "2002"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Janeway,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.173: Medzhitov. 

Phrase: "Medzhitov."
Processing 00000000.tx.174: 2002. 

Phrase: "2002."
Processing 00000000.tx.175: Innate immune recognition. 

Phrase: "Innate immune recognition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524637:Recognition [Mental Process]
Processing 00000000.tx.176: Annu. 

Phrase: "Annu."
Processing 00000000.tx.177: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.178: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.179: 20:197216.[CrossRef][Medline] Akira, S., K. 

Phrase: "20"

Phrase: ":"

Phrase: "197216."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Akira,"

Phrase: "S."

Phrase: ","

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.180: Takeda, and T. 

Phrase: "Takeda,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.181: Kaisho. 

Phrase: "Kaisho."
Processing 00000000.tx.182: 2001. 

Phrase: "2001."
Processing 00000000.tx.183: Toll-like receptors: critical proteins linking innate and acquired immunity. 

Phrase: "Toll-like receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0670896:Toll-like receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   827   C1336636:TOLL [Gene or Genome]
   827   C1705581:TOLL [Gene or Genome]

Phrase: ":"

Phrase: "critical proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "innate"

Phrase: "and"

Phrase: "acquired immunity."
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0678209:Acquired Immunity [Physiologic Function]
  1000   C3536951:Acquired Immunity [Physiologic Function]
   861   C0020964:Immunity [Physiologic Function]
   861   C0439661:Acquired [Temporal Concept]
   861   C3245488:acquired [Intellectual Product]
   827 E C1706701:Acquire [Activity]
   789 E C0439662:Immune [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0205217:Increased [Quantitative Concept]
   768 E C0442805:Increase [Functional Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
Processing 00000000.tx.184: Nat. 

Phrase: "Nat."
Processing 00000000.tx.185: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.186: 2:675680.[CrossRef][Medline] Krieg, A.M. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "675680."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krieg,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.187: 2002. 

Phrase: "2002."
Processing 00000000.tx.188: CpG motifs in bacterial DNA and their immune effects. 

Phrase: "CpG motifs in bacterial DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3178798:DNA Motifs [Nucleotide Sequence]
   726   C1514562:Motif [Amino Acid Sequence]

Phrase: "and"

Phrase: "their immune effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.189: Annu. 

Phrase: "Annu."
Processing 00000000.tx.190: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.191: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.192: 20:709760.[CrossRef][Medline] Klinman, D.M., D. 

Phrase: "20"

Phrase: ":"

Phrase: "709760."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klinman,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "D."
Processing 00000000.tx.193: Verthelyi, F. 

Phrase: "Verthelyi,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.194: Takeshita, and K.J. 

Phrase: "Takeshita,"

Phrase: "and"

Phrase: "K.J."
Processing 00000000.tx.195: Ishii. 

Phrase: "Ishii."
Processing 00000000.tx.196: 1999. 

Phrase: "1999."
Processing 00000000.tx.197: Immune recognition of foreign DNA: a cure for bioterrorism? 

Phrase: "Immune recognition of foreign DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0524637:Recognition [Mental Process]

Phrase: ":"

Phrase: "a cure for bioterrorism?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880198:Cure [Conceptual Entity]
Processing 00000000.tx.198: Immunity. 

Phrase: "Immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.199: 11:123129.[Medline] Wagner, H. 

Phrase: "11"

Phrase: ":"

Phrase: "123129."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wagner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.200: 1999. 

Phrase: "1999."
Processing 00000000.tx.201: Bacterial CpG DNA activates immune cells to signal infectious danger. 

Phrase: "Bacterial CpG DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "immune cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "infectious danger."
Processing 00000000.tx.202: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.203: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.204: 73:329368.[Medline] Yamamoto, S., T. 

Phrase: "73"

Phrase: ":"

Phrase: "329368."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "S."

Phrase: ","

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.205: Yamamoto, and T. 

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.206: Tokunaga. 

Phrase: "Tokunaga."
Processing 00000000.tx.207: 2000. 

Phrase: "2000."
Processing 00000000.tx.208: The discovery of immunostimulatory DNA sequence. 

Phrase: "The discovery of immunostimulatory DNA sequence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880355:Discovery [Activity]
Processing 00000000.tx.209: Springer Semin. 

Phrase: "Springer Semin."
Processing 00000000.tx.210: Immunopathol. 

Phrase: "Immunopathol."
Processing 00000000.tx.211: 22:1119.[CrossRef][Medline] Hemmi, H., O. 

Phrase: "22"

Phrase: ":"

Phrase: "1119."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hemmi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.212: Takeuchi, T. 

Phrase: "Takeuchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.213: Kawai, T. 

Phrase: "Kawai,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.214: Kaisho, S. 

Phrase: "Kaisho,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.215: Sato, H. 

Phrase: "Sato,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.216: Sanjo, M. 

Phrase: "Sanjo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.217: Matsumoto, K. 

Phrase: "Matsumoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.218: Hoshino, H. 

Phrase: "Hoshino,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.219: Wagner, K. 

Phrase: "Wagner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.220: Takeda, and S. 

Phrase: "Takeda,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.221: Akira. 

Phrase: "Akira."
Processing 00000000.tx.222: 2000. 

Phrase: "2000."
Processing 00000000.tx.223: A Toll-like receptor recognizes bacterial DNA. 

Phrase: "A Toll-like receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0670896:Toll-Like Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   827   C1336636:TOLL [Gene or Genome]
   827   C1705581:TOLL [Gene or Genome]

Phrase: "recognizes"

Phrase: "bacterial DNA."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521009:Bacterial [Qualitative Concept]
   789 E C0004611:Bacteria [Bacterium]
   789 E C1510439:bacteria [Functional Concept]
   789 E C2347473:% Bacteria [Quantitative Concept]
Processing 00000000.tx.224: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.225: 408:740745.[CrossRef][Medline] Bauer, S., C.J. 

Phrase: "408"

Phrase: ":"

Phrase: "740745."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bauer,"

Phrase: "S."

Phrase: ","

Phrase: "C.J."
Processing 00000000.tx.226: Kirschning, H. 

Phrase: "Kirschning,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.227: Hacker, V. 

Phrase: "Hacker,"

Phrase: "V."
Processing 00000000.tx.228: Redecke, S. 

Phrase: "Redecke,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.229: Hausmann, S. 

Phrase: "Hausmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.230: Akira, H. 

Phrase: "Akira,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.231: Wagner, and G.B. 

Phrase: "Wagner,"

Phrase: "and"

Phrase: "G.B."
Processing 00000000.tx.232: Lipford. 

Phrase: "Lipford."
Processing 00000000.tx.233: 2001. 

Phrase: "2001."
Processing 00000000.tx.234: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. 

Phrase: "Human TLR9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1423633:TLR9 [Gene or Genome]

Phrase: "confers"

Phrase: "responsiveness to bacterial DNA"

Phrase: "via species-specific CpG motif recognition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0524637:Recognition [Mental Process]
Processing 00000000.tx.235: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.236: Natl. 

Phrase: "Natl."
Processing 00000000.tx.237: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.238: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.239: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.240: 98:92379242.[Abstract/Free FullText] Takeshita, F., C.A. 

Phrase: "98"

Phrase: ":"

Phrase: "92379242."

Phrase: "[Abstract/Free FullText"

Phrase: "] Takeshita,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.241: Leifer, I. 

Phrase: "Leifer,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.242: Gursel, K.J. 

Phrase: "Gursel,"

Phrase: "K.J."
Processing 00000000.tx.243: Ishii, S. 

Phrase: "Ishii,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.244: Takeshita, M. 

Phrase: "Takeshita,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.245: Gursel, and D.M. 

Phrase: "Gursel,"

Phrase: "and"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.246: Klinman. 

Phrase: "Klinman."
Processing 00000000.tx.247: 2001. 

Phrase: "2001."
Processing 00000000.tx.248: Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. 

Phrase: "Cutting edge"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0152060:Cutting, NOS [Therapeutic or Preventive Procedure]
   861   C0205154:Edge [Spatial Concept]
   861   C1306235:Cutting [Qualitative Concept]
   861   C2697523:Edge [Conceptual Entity]
   861   C3496294:Cutting [Functional Concept]
   827 E C0000925:Cut [Injury or Poisoning]
   827 E C1883724:CUT [Phenomenon or Process]

Phrase: ":"

Phrase: "role of Toll-like receptor 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0963057:Toll-like receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   716   C1309709:Toll-Like Receptor 9 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   716   C1423633:TOLL-LIKE RECEPTOR 9 [Gene or Genome]

Phrase: "in CpG DNA-induced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "of human cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.249: J. 

Phrase: "J."
Processing 00000000.tx.250: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.251: 167:35553558.[Abstract/Free FullText] Chu, W., X. 

Phrase: "167"

Phrase: ":"

Phrase: "35553558."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chu,"

Phrase: "W.,"

Phrase: "X."
Processing 00000000.tx.252: Gong, Z. 

Phrase: "Gong,"

Phrase: "Z."
Processing 00000000.tx.253: Li, K. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.254: Takabayashi, H. 

Phrase: "Takabayashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.255: Ouyang, Y. 

Phrase: "Ouyang,"

Phrase: "Y."
Processing 00000000.tx.256: Chen, A. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "A."
Processing 00000000.tx.257: Lois, D.J. 

Phrase: "Lois,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.258: Chen, G.C. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.C."
Processing 00000000.tx.259: Li, M. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.260: Karin, and E. 

Phrase: "Karin,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.261: Raz. 

Phrase: "Raz."
Processing 00000000.tx.262: 2000. 

Phrase: "2000."
Processing 00000000.tx.263: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. 

Phrase: "DNA-PKcs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "required for activation of innate immunity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0020969:Immunity, Innate [Organism Attribute,Pathologic Function]
   753   C0020964:Immunity [Physiologic Function]
   753   C1514873:Required [Functional Concept]
   753   C1879547:Activation [Activity]

Phrase: "by immunostimulatory DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.264: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.265: 103:909918.[Medline] Aderem, A., and D.A. 

Phrase: "103"

Phrase: ":"

Phrase: "909918."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aderem,"

Phrase: "A.,"

Phrase: "and"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.266: Hume. 

Phrase: "Hume."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476794:Hume [Intellectual Product]
Processing 00000000.tx.267: 2000. 

Phrase: "2000."
Processing 00000000.tx.268: How do you see CG? 

Phrase: "How"

Phrase: "do"

Phrase: "you"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "CG?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3540479:CG [Gene or Genome]
Processing 00000000.tx.269: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.270: 103:993996.[Medline] Katso, R., K. 

Phrase: "103"

Phrase: ":"

Phrase: "993996."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katso,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.271: Okkenhaug, K. 

Phrase: "Okkenhaug,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.272: Ahmadi, S. 

Phrase: "Ahmadi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998054:Ahmadi [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.273: White, J. 

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.274: Timms, and M.D. 

Phrase: "Timms,"

Phrase: "and"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.275: Waterfield. 

Phrase: "Waterfield."
Processing 00000000.tx.276: 2001. 

Phrase: "2001."
Processing 00000000.tx.277: Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. 

Phrase: "Cellular function of phosphoinositide 3-kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0007613:Cellular Function [Cell Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "implications for development,"

Phrase: "homeostasis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.278: Annu. 

Phrase: "Annu."
Processing 00000000.tx.279: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.280: Cell Dev. 

Phrase: "Cell Dev."
Processing 00000000.tx.281: Biol. 

Phrase: "Biol."
Processing 00000000.tx.282: 17:615675.[CrossRef][Medline] Wymann, M.P., and L. 

Phrase: "17"

Phrase: ":"

Phrase: "615675."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wymann,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.283: Pirola. 

Phrase: "Pirola."
Processing 00000000.tx.284: 1998. 

Phrase: "1998."
Processing 00000000.tx.285: Structure and function of phosphoinositide 3-kinases. 

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "function of phosphoinositide 3-kinases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.286: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.287: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.288: Acta. 

Phrase: "Acta."
Processing 00000000.tx.289: 1436:127150.[Medline] Underhill, D.M., and A. 

Phrase: "1436"

Phrase: ":"

Phrase: "127150."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Underhill,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.290: Ozinsky. 

Phrase: "Ozinsky."
Processing 00000000.tx.291: 2002. 

Phrase: "2002."
Processing 00000000.tx.292: Phagocytosis of microbes: complexity in action. 

Phrase: "Phagocytosis of microbes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0031308:Phagocytosis [Cell Function]

Phrase: ":"

Phrase: "complexity in action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   718   C0439855:Complex [Qualitative Concept]
   718   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.293: Annu. 

Phrase: "Annu."
Processing 00000000.tx.294: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.295: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.296: 20:825852.[CrossRef][Medline] Gillooly, D.J., A. 

Phrase: "20"

Phrase: ":"

Phrase: "825852."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gillooly,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A."
Processing 00000000.tx.297: Simonsen, and H. 

Phrase: "Simonsen,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.298: Stenmark. 

Phrase: "Stenmark."
Processing 00000000.tx.299: 2001. 

Phrase: "2001."
Processing 00000000.tx.300: Phosphoinositides and phagocytosis. 

Phrase: "Phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "phagocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:Phagocytosis [Cell Function]
Processing 00000000.tx.301: J. 

Phrase: "J."
Processing 00000000.tx.302: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.303: 155:1517.[Abstract/Free FullText] Vieira, O.V., R.J. 

Phrase: "155"

Phrase: ":"

Phrase: "1517."

Phrase: "[Abstract/Free FullText"

Phrase: "] Vieira,"

Phrase: "O.V., R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.304: Botelho, L. 

Phrase: "Botelho,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.305: Rameh, S.M. 

Phrase: "Rameh,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.306: Brachmann, T. 

Phrase: "Brachmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.307: Matsuo, H.W. 

Phrase: "Matsuo,"

Phrase: "H.W."
Processing 00000000.tx.308: Davidson, A. 

Phrase: "Davidson,"

Phrase: "A."
Processing 00000000.tx.309: Schreiber, J.M. 

Phrase: "Schreiber,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.310: Backer, L.C. 

Phrase: "Backer,"

Phrase: "L.C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.311: Cantley, and S. 

Phrase: "Cantley,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.312: Grinstein. 

Phrase: "Grinstein."
Processing 00000000.tx.313: 2001. 

Phrase: "2001."
Processing 00000000.tx.314: Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. 

Phrase: "Distinct roles of class I"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "class III phosphatidylinositol 3-kinases in phagosome formation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   869   C2936441:Class III Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   800   C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   789 E C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "maturation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.315: J. 

Phrase: "J."
Processing 00000000.tx.316: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.317: 155:1925.[Abstract/Free FullText] Fratti, R.A., J.M. 

Phrase: "155"

Phrase: ":"

Phrase: "1925."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fratti,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.318: Backer, J. 

Phrase: "Backer,"

Phrase: "J."
Processing 00000000.tx.319: Gruenberg, S. 

Phrase: "Gruenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.320: Corvera, and V. 

Phrase: "Corvera,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.321: Deretic. 

Phrase: "Deretic."
Processing 00000000.tx.322: 2001. 

Phrase: "2001."
Processing 00000000.tx.323: Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. 

Phrase: "Role of phosphatidylinositol 3-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "Rab5 effectors in phagosomal biogenesis"

Phrase: "and"

Phrase: "mycobacterial phagosome maturation arrest."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C0333951:Maturation arrest [Pathologic Function]
   861   C3157010:phagosome maturation [Cell Function]
   812   C0237477:Arrest [Temporal Concept]
   812   C0392351:arrest [Governmental or Regulatory Activity]
   812   C0678723:Maturation [Organism Function]
   812   C0870861:maturation [Phenomenon or Process]
   812   C1254042:Maturation [Physiologic Function]
   756 E C0311403:Inhibited [Qualitative Concept]
   756 E C3463820:Inhibiting [Activity]
   729 E C0018790:arrested [Disease or Syndrome]
   729 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.324: J. 

Phrase: "J."
Processing 00000000.tx.325: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.326: 154:631644.[Abstract/Free FullText] Stein, R.C., and M.D. 

Phrase: "154"

Phrase: ":"

Phrase: "631644."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stein,"

Phrase: "R.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.327: Waterfield. 

Phrase: "Waterfield."
Processing 00000000.tx.328: 2000. 

Phrase: "2000."
Processing 00000000.tx.329: PI3-kinase inhibition: a target for drug development? 

Phrase: "PI3-kinase inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "a target for drug development?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0085104:drug target [Medical Device]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.330: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.331: Med. 

Phrase: "Med."
Processing 00000000.tx.332: Today. 

Phrase: "Today."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0310367:Today [Antibiotic,Organic Chemical]
  1000   C0750526:Today [Temporal Concept]
Processing 00000000.tx.333: 6:347357.[CrossRef][Medline] Gu, Y., S. 

Phrase: "6"

Phrase: ":"

Phrase: "347357."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gu,"

Phrase: "Y.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.334: Jin, Y. 

Phrase: "Jin,"

Phrase: "Y."
Processing 00000000.tx.335: Gao, D.T. 

Phrase: "Gao,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.336: Weaver, and F.W. 

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "and"

Phrase: "F.W."
Processing 00000000.tx.337: Alt. 

Phrase: "Alt."
Processing 00000000.tx.338: 1997. 

Phrase: "1997."
Processing 00000000.tx.339: Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. 

Phrase: "Ku70-deficient embryonic stem cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0596508:Embryonic Stem Cells [Cell]
   840   C0038250:Stem cells [Cell]
   836   C1947950:Embryonic Cell [Embryonic Structure]
   804   C0007634:Cells [Cell]
   804   C0013935:Embryonic [Embryonic Structure]
   804   C0242767:Stem [Plant]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "ionizing"

Phrase: "radiosensitivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034537:Radiosensitivity [Organism Attribute]

Phrase: "defective DNA end-binding activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C1148734:DNA end binding [Genetic Function]

Phrase: "and"

Phrase: "inability to"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "V(D)J recombination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519877:V(D)J Recombination [Genetic Function]
           V-J recombination
   812   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.340: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.341: Natl. 

Phrase: "Natl."
Processing 00000000.tx.342: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.343: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.344: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.345: 94:80768081.[Abstract/Free FullText] Gao, Y., J. 

Phrase: "94"

Phrase: ":"

Phrase: "80768081."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gao,"

Phrase: "Y.,"

Phrase: "J."
Processing 00000000.tx.346: Chaudhuri, C. 

Phrase: "Chaudhuri,"

Phrase: "C."
Processing 00000000.tx.347: Zhu, L. 

Phrase: "Zhu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.348: Davidson, D.T. 

Phrase: "Davidson,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.349: Weaver, and F.W. 

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "and"

Phrase: "F.W."
Processing 00000000.tx.350: Alt. 

Phrase: "Alt."
Processing 00000000.tx.351: 1998. 

Phrase: "1998."
Processing 00000000.tx.352: A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for Ku in V(D)J recombination. 

Phrase: "A targeted DNA-PKcs-null mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0079870:Targeted Mutation [Genetic Function]
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "DNA-PK-independent functions for Ku"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0815043:function protein [Amino Acid, Peptide, or Protein]
   757   C1527118:Protein Function [Molecular Function]
   748   C0542341:Functions [Functional Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "in V(D)J recombination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519877:V(D)J Recombination [Genetic Function]
           V-J recombination
   812   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.353: Immunity. 

Phrase: "Immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.354: 9:367376.[Medline] Nussenzweig, A., C. 

Phrase: "9"

Phrase: ":"

Phrase: "367376."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nussenzweig,"

Phrase: "A.,"

Phrase: "C."
Processing 00000000.tx.355: Chen, V. da Costa Soares, M. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "V. da Costa Soares,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: Sanchez, K. 

Phrase: "Sanchez,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.357: Sokol, M.C. 

Phrase: "Sokol,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.358: Nussenzweig, and G.C. 

Phrase: "Nussenzweig,"

Phrase: "and"

Phrase: "G.C."
Processing 00000000.tx.359: Li. 

Phrase: "Li."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.360: 1996. 

Phrase: "1996."
Processing 00000000.tx.361: Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. 

Phrase: "Requirement for Ku80 in growth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "immunoglobulin V(D)J recombination."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2246553:immunoglobulin V(D)J recombination [Genetic Function]
           immunoglobulin V-J recombination
  1000   C2825089:immunoglobulin V(D)J recombination [Genetic Function]
   937   C1519877:V(D)J Recombination [Genetic Function]
           V-J recombination
   804   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.362: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.363: 382:551555.[CrossRef][Medline] Ishii, K.J., K. 

Phrase: "382"

Phrase: ":"

Phrase: "551555."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishii,"

Phrase: "K.J.,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.364: Suzuki, C. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "C."
Processing 00000000.tx.365: Coban, F. 

Phrase: "Coban,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917861:Coban [Antibiotic,Organic Chemical]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.366: Takeshita, Y. 

Phrase: "Takeshita,"

Phrase: "Y."
Processing 00000000.tx.367: Itoh, H. 

Phrase: "Itoh,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.368: Matoba, L.D. 

Phrase: "Matoba,"

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.369: Kohn, and D.M. 

Phrase: "Kohn,"

Phrase: "and"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: Klinman. 

Phrase: "Klinman."
Processing 00000000.tx.371: 2001. 

Phrase: "2001."
Processing 00000000.tx.372: Genomic DNA released by dying cells induces the maturation of APCs. 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "released by dying cells"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0184532:dying [Organism Function]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the maturation of APCs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678723:Maturation [Organism Function]
   770   C0870861:maturation [Phenomenon or Process]
   770   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.375: 167:26022607.[Abstract/Free FullText] Klinman, D.M., A.K. 

Phrase: "167"

Phrase: ":"

Phrase: "26022607."

Phrase: "[Abstract/Free FullText"

Phrase: "] Klinman,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.376: Yi, S.L. 

Phrase: "Yi,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.377: Beaucage, J. 

Phrase: "Beaucage,"

Phrase: "J."
Processing 00000000.tx.378: Conover, and A.M. 

Phrase: "Conover,"

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: Krieg. 

Phrase: "Krieg."
Processing 00000000.tx.380: 1996. 

Phrase: "1996."
Processing 00000000.tx.381: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon . Proc. 

Phrase: "CpG motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "present in bacteria DNA rapidly"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0012924:DNA, Bacterial [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0004611:Bacteria [Bacterium]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1510439:bacteria [Functional Concept]
   760   C1637379:Rapidly [Qualitative Concept]
   760   C2347473:% Bacteria [Quantitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "lymphocytes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "interleukin 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interleukin 12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0123759:Interleukin-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1524115:Interleukin 12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "interferon . Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.382: Natl. 

Phrase: "Natl."
Processing 00000000.tx.383: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.384: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.385: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.386: 93:28792883.[Abstract/Free FullText] Sahlin, S., J. 

Phrase: "93"

Phrase: ":"

Phrase: "28792883."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sahlin,"

Phrase: "S."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.387: Hed, and I. 

Phrase: "Hed,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0406702:HED [Congenital Abnormality,Disease or Syndrome]
  1000   C3539567:Hed [Gene or Genome]
  1000   C3539920:HED [Disease or Syndrome]
  1000   C3541517:HED [Disease or Syndrome]

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.388: Rundquist. 

Phrase: "Rundquist."
Processing 00000000.tx.389: 1983. 

Phrase: "1983."
Processing 00000000.tx.390: Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. 

Phrase: "Differentiation between attached"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "ingested immune complexes by a fluorescence quenching cytofluorometric assay."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   784   C1261356:Immune complexes assay [Laboratory Procedure]
   764   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1442775:IMMUNE FLUORESCENCE [Laboratory Procedure]
   742   C0439662:Immune [Functional Concept]
   742   C1704241:Complexes [Chemical Viewed Structurally]
   708 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.391: J. 

Phrase: "J."
Processing 00000000.tx.392: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.393: Methods. 

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.394: 60:115124.[CrossRef][Medline] Krieg, A.M., A.K. 

Phrase: "60"

Phrase: ":"

Phrase: "115124."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krieg,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.395: Yi, S. 

Phrase: "Yi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.396: Matson, T.J. 

Phrase: "Matson,"

Phrase: "T.J."
Processing 00000000.tx.397: Waldschmidt, G.A. 

Phrase: "Waldschmidt,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.398: Bishop, R. 

Phrase: "Bishop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551458:Bishop [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: Teasdale, G.A. 

Phrase: "Teasdale,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.400: Koretzky, and D.M. 

Phrase: "Koretzky,"

Phrase: "and"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.401: Klinman. 

Phrase: "Klinman."
Processing 00000000.tx.402: 1995. 

Phrase: "1995."
Processing 00000000.tx.403: CpG motifs in bacterial DNA trigger direct B-cell activation. 

Phrase: "CpG motifs in bacterial DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3178798:DNA Motifs [Nucleotide Sequence]
   726   C1514562:Motif [Amino Acid Sequence]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "direct B-cell activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1155003:B-Cell Activation [Cell Function]
   923   C1332420:B-cell activation [Gene or Genome]
   861   C1326120:cell activation [Cell Function]
   812   C1879547:Activation [Activity]
Processing 00000000.tx.404: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.405: 374:546549.[Medline] Park, Y., S.W. 

Phrase: "374"

Phrase: ":"

Phrase: "546549."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "Y.,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.406: Lee, and Y.C. 

Phrase: "Lee,"

Phrase: "and"

Phrase: "Y.C."
Processing 00000000.tx.407: Sung. 

Phrase: "Sung."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]
Processing 00000000.tx.408: 2002. 

Phrase: "2002."
Processing 00000000.tx.409: Cutting edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway. 

Phrase: "Cutting edge"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0152060:Cutting, NOS [Therapeutic or Preventive Procedure]
   861   C0205154:Edge [Spatial Concept]
   861   C1306235:Cutting [Qualitative Concept]
   861   C2697523:Edge [Conceptual Entity]
   861   C3496294:Cutting [Functional Concept]
   827 E C0000925:Cut [Injury or Poisoning]
   827 E C1883724:CUT [Phenomenon or Process]

Phrase: ":"

Phrase: "CpG DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "dendritic cell apoptosis by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C3157086:dendritic cell apoptosis [Cell Function]
   770   C0162638:Apoptosis [Cell Function]

Phrase: "up-regulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "cellular inhibitor of apoptosis proteins"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   937   C0893445:Inhibitor of Apoptosis Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007634:Cellular [Cell]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0162638:Apoptosis [Cell Function]
   804   C0178539:Cellular [Functional Concept]
   804   C1999216:Inhibitor [Qualitative Concept]
   733 E C1516044:Apoptotic [Qualitative Concept]
   733 E C1516377:Cellularity [Qualitative Concept]

Phrase: "through the phosphatidylinositide-3'-OH kinase pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.410: J. 

Phrase: "J."
Processing 00000000.tx.411: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.412: 168:58.[Abstract/Free FullText]

Phrase: "168"

Phrase: ":"

Phrase: "58."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

